Development of therapeutic cancer vaccines : Los Angeles Airport Renaissance Hotel, California, USA, April 27-29, 2004

History of Tumour Vaccines and Novel Approaches for Preventive Cancer Vaccines: Finn, O. Are Cancer Vaccines Really the Same as Infectious Disease Vaccines?: Petricciani, J. Keynote Address: P. Noguchi Combinatorial Vaccine Strategies and the Use of Molecular Arrays to Characterize T-Cell Activation: Schlom, J. et al. Regulatory Considerations in Tumour Vaccine Development Preclinical Safety Studies in the Development of Tumour Vaccines (Abstract): Essayan, D.M. Regulatory Expectations During Product Development for Tumour Vaccines: Kawakami, K. Puri, R.K. Lessons from Preventive Infectious Disease Vaccines: Chandler, D.K.F. Midthun, K. Goldenthal, K.L. Clinical Development of Tumour Vaccines (Abstract): Keegan, P. Autologous and Allogeneic: Cellular and Acellular Tumour Vaccines Characterization of Polyvalent Allogeneic Vaccines: Van Epps, D. Defined Antigens and Allogeneic Tumour Lysates as Cancer Vaccines (Abstract): Cheever, M.A. Manipulating the Host Response to Autologous Tumour Vaccines: Ma, J. et al. Autologous Heat Shock Protein-Peptide Complexes for Vaccination Against Cancer: From Bench to Bedside: Hoos, A. Levey, D.L. Lewis, J.J. Recombinant Cancer Vaccines Based on Viral Vectors: Moingeon, P. Vaccination of Cancer Patients with Tumour Antigens Recognized by T Lymphocytes (Abstract): Boon, T. Characterization of Autologous and Allogeneic Tumour Cells: Borellini, F. Dendritic Cells (DC) as Tumour Vaccines Dendritic Cells as Melanoma Vaccines: Banchereau, J. et al. APC Vaccines: Product Characterization and Clinical Development (Abstract): Peshwa, M.V. Clinical Trials with Dendritic Cells: an Update of Product Developments and Clinical Trials (Abstract): Mule, J.J. Dendritic Cell/Tumour Fusions Vaccine: Avigan, D. Therapeutic Vaccine Generated by Electrofusion of Dendritic Cells and Tumour Cells: Kuriyama, H. et al. Preventive Tumour Vaccines, Clinical Strategies and Immunological Assessment in Early Clinical Trials E6, E7 and VLP Based Papillomavirus Vaccines for Prevention of Cervical Cancer (Abstract): Frazer, I. Hepatitis C Vaccines to Prevent Liver Cancer (Abstract): Houghton, M. CoVal[trademark] Fusions: A Therapeutic Vaccine Platform Using Heat Shock Proteins to Treat Chronic Viral Infection and Cancer: Neefe, J.R. Chu, N.R. Mizzen, L. Immunotherapeutic Strategies for Melanoma: The Role of Anatomic Site in Vaccination and Immune Monitoring (Abstract): Hwu, P. Assays for Monitoring a CEA Peptide-Induced Immunological Response in Dendritic Cell Trials (Abstract): Lyerly, H.K. Precision Guiding of Cytolytic T-Lymphocyte Responses (Abstract): Melief, C.J.M. et al. Effective Peptide Vaccines for Melanoma (Abstract): Weber, J.S. Immune Response to Postsurgical Adjuvant Active Immunotherapy with Canvaxin Polyvalent Cancer Vaccine: Correlations with Clinical Course of Patients with Metastatic Melanoma: Morton, D.L. Methods to Monitor Immune Response and Quality Control: Whiteside, T.L.